Search in:

Cancer Biology & Therapy Volume 22, 2021 - Issue 2

Submit an article Journal homepage

Open access

4,501

Views

CrossRef citations to date

Altmetric

Review

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

Rebecca C. Arenda Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]
View further author information

Amy Jackson-Fisherb Translational Medicine, Pfizer, San Diego, CA, USAView further author information

Ira A. Jacobsc U.S. Enterprise, Pfizer, NY, New York, USACorrespondence[email protected]
View further author information

Jeffrey Choud Research and Development, Pfizer, San Francisco, CA, USAView further author information

Bradley J. Monke US Oncology, Research Gynecology Program, Phoenix, AZ, USAView further author information

Pages 89-105 | Received 07 May 2020, Accepted 22 Dec 2020, Published online: 11 Jan 2021

Cite this article
https://doi.org/10.1080/15384047.2020.1868937
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Cornelia Bachmann. (2023) New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review. Cancers 15:22, pages 5356.
Crossref

Jia Mai, Limei Wu, Ling Yang, Ting Sun, Xiaojuan Liu, Rutie Yin, Yongmei Jiang, Jinke Li & Qintong Li. (2023) Therapeutic strategies targeting folate receptor α for ovarian cancer. Frontiers in Immunology 14.
Crossref

Sandra Domínguez-Llamas, Manuel Caro-Magdaleno, Beatriz Mataix-Albert, Javier Avilés-Prieto, Isabel Romero-Barranca & Enrique Rodríguez-de-la-Rúa. (2023) Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy. Clinical and Translational Oncology.
Crossref

Xuejian Li, Huifei Wang, Aran Jia, Yuanyuan Cao, Liuqing Yang & Zanhui Jia. (2023) LGALS1 regulates cell adhesion to promote the progression of ovarian cancer. Oncology Letters 26:2.
Crossref

Balázs Győrffy. (2023) Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. GeroScience 45:3, pages 1889-1898.
Crossref

Mitra Torabi, Ayuob Aghanejad, Pouria Savadi, Abolfazl Barzegari, Yadollah Omidi & Jaleh Barar. (2023) Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles. Molecules 28:1, pages 411.
Crossref

Nail Paksoy, Nijat Khanmammadov, İzzet Doğan, Ferhat Ferhatoğlu, Anil Yildiz, Naziye Ak & Adnan Aydiner. (2022) Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine 101:45, pages e31726.
Crossref

Leon J. Spicer, John R. Evans & Nicole B. Schreiber. (2022) Hormone regulation of thrombospondin-1 mRNA in porcine granulosa cells in vitro. Animal Reproduction Science 244, pages 107048.
Crossref

Fatemeh Sadoughi, Zatollah Asemi, Jamal Hallajzadeh, Mohammad Ali Mansournia & Bahman Yousefi. (2022) Beta-glucans is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects. Current Pharmaceutical Biotechnology 23:9, pages 1142-1152.
Crossref

Robert Kubina, Kamil Krzykawski, Agata Kabała-Dzik, Robert D. Wojtyczka, Ewa Chodurek & Arkadiusz Dziedzic. (2022) Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. Nutrients 14:13, pages 2604.
Crossref

Yiming Jia, Jingru Li, Jinfeng Wang, Tianjiao Luo, Xiaoqian Jing & Hongmin Zhao. (2022) Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway. Analytical Cellular Pathology 2022, pages 1-12.
Crossref

SHUTING GU, JINGYI QIN, SAINAN GAO, ZHEN WANG, QI MENG, YAN LI, BING LU, SONGLIN ZHOU & YUNZHAO XU. (2022) KIAA1199 induces advanced biological behavior and development of ovarian cancer through activation of the IL-6/STAT3 pathway. BIOCELL 46:3, pages 689-697.
Crossref

Du-Bois Asante, Michael Morici, Ganendra R. K. A. Mohan, Emmanuel Acheampong, Isaac Spencer, Weitao Lin, Paula van Miert, Samantha Gibson, Aaron B. Beasley, Melanie Ziman, Leslie Calapre, Tarek M. Meniawy & Elin S. Gray. (2021) Multi-Marker Immunofluorescent Staining and PD-L1 Detection on Circulating Tumour Cells from Ovarian Cancer Patients. Cancers 13:24, pages 6225.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date